CSL Ltd Total Liabilities
CSL Ltd total liabilities. Based on the latest financial reports, CSL Ltd (CSL) has total liabilities worth AU$18.06 Billion AUD (≈ $12.78 Billion USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of CSL Ltd to evaluate the company's liquid asset resilience ratio.
Total Liabilities of CSL Ltd (1993–2025)
Total liabilities of CSL Ltd from 1993 to 2025. This chart illustrates how CSL Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore CSL long-term investments to assets to see how much of total assets are deployed in long-term investments.
CSL Ltd Competitors by Total Liabilities
The table below lists competitors of CSL Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Applovin Corp
NASDAQ:APP
|
USA | $5.11 Billion |
|
Fubon Financial Holding Co Ltd
TW:2881
|
Taiwan | NT$11.85 Trillion |
|
Cloudflare Inc
NYSE:NET
|
USA | $4.44 Billion |
|
Cummins Inc
NYSE:CMI
|
USA | $21.07 Billion |
|
Airbnb Inc
NASDAQ:ABNB
|
USA | $19.19 Billion |
|
Eni S.p.A
F:ENI1
|
Germany | €93.42 Billion |
|
Kinder Morgan Inc
NYSE:KMI
|
USA | $41.18 Billion |
|
Vingroup JSC
VN:VIC
|
Vietnam | ₫1128.23 Trillion |
Liability Composition Analysis (1993–2025)
This chart breaks down CSL Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see CSL current and non-current assets.
Liquidity & Leverage Metrics
CSL Ltd Total Liabilities Ratios Explained
CSL Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.46 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.93 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.46 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how CSL Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for CSL Ltd (1993–2025)
The table below shows the annual total liabilities of CSL Ltd from 1993 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | AU$18.00 Billion ≈ $12.73 Billion |
-3.35% |
| 2024-06-30 | AU$18.62 Billion ≈ $13.18 Billion |
-32.66% |
| 2023-06-30 | AU$27.65 Billion ≈ $19.57 Billion |
+38.12% |
| 2022-06-30 | AU$20.02 Billion ≈ $14.17 Billion |
+105.59% |
| 2021-06-30 | AU$9.74 Billion ≈ $6.89 Billion |
+8.97% |
| 2020-06-30 | AU$8.94 Billion ≈ $6.32 Billion |
+27.65% |
| 2019-06-30 | AU$7.00 Billion ≈ $4.95 Billion |
+5.57% |
| 2018-06-30 | AU$6.63 Billion ≈ $4.69 Billion |
+11.30% |
| 2017-06-30 | AU$5.96 Billion ≈ $4.22 Billion |
+19.89% |
| 2016-06-30 | AU$4.97 Billion ≈ $3.52 Billion |
+78.87% |
| 2015-06-30 | AU$2.78 Billion ≈ $1.97 Billion |
-10.81% |
| 2014-06-30 | AU$3.12 Billion ≈ $2.20 Billion |
+4.95% |
| 2013-06-30 | AU$2.97 Billion ≈ $2.10 Billion |
+19.91% |
| 2012-06-30 | AU$2.48 Billion ≈ $1.75 Billion |
+52.13% |
| 2011-06-30 | AU$1.63 Billion ≈ $1.15 Billion |
+51.89% |
| 2010-06-30 | AU$1.07 Billion ≈ $758.09 Million |
-12.78% |
| 2009-06-30 | AU$1.23 Billion ≈ $869.16 Million |
-32.03% |
| 2008-06-30 | AU$1.81 Billion ≈ $1.28 Billion |
+30.20% |
| 2007-06-30 | AU$1.39 Billion ≈ $982.06 Million |
+15.38% |
| 2006-06-30 | AU$1.20 Billion ≈ $851.12 Million |
+15.75% |
| 2005-06-30 | AU$1.04 Billion ≈ $735.33 Million |
-17.48% |
| 2004-06-30 | AU$1.26 Billion ≈ $891.11 Million |
+193.86% |
| 2003-06-30 | AU$428.58 Million ≈ $303.24 Million |
-26.73% |
| 2002-06-30 | AU$584.95 Million ≈ $413.89 Million |
+148.92% |
| 2001-06-30 | AU$235.00 Million ≈ $166.27 Million |
+328.91% |
| 2000-06-30 | AU$54.79 Million ≈ $38.77 Million |
-15.82% |
| 1999-06-30 | AU$65.08 Million ≈ $46.05 Million |
+27.24% |
| 1998-06-30 | AU$51.15 Million ≈ $36.19 Million |
-54.16% |
| 1997-06-30 | AU$111.59 Million ≈ $78.96 Million |
+34.88% |
| 1996-06-30 | AU$82.73 Million ≈ $58.54 Million |
+15.84% |
| 1995-06-30 | AU$71.42 Million ≈ $50.53 Million |
-12.21% |
| 1994-06-30 | AU$81.35 Million ≈ $57.56 Million |
+151.07% |
| 1993-06-30 | AU$32.40 Million ≈ $22.93 Million |
-- |
About CSL Ltd
CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma produ… Read more